Related references
Note: Only part of the references are listed.Response evaluation criteria for peripheral nodal lymphoma in dogs (v1.0)-a veterinary cooperative oncology group (VCOG) consensus document
D. M. Vail et al.
VETERINARY AND COMPARATIVE ONCOLOGY (2010)
Asparaginase and MOPP Treatment of Dogs with Lymphoma
E. M. Brodsky et al.
JOURNAL OF VETERINARY INTERNAL MEDICINE (2009)
Comparative analysis of survivin expression in untreated and relapsed canine lymphoma
R. B. Rebhun et al.
JOURNAL OF VETERINARY INTERNAL MEDICINE (2008)
Inactivation of the p16 cyclin-dependent kinase inhibitor in high-grade canine non-Hodgkin's T-Cell lymphoma
S. P. Fosmire et al.
VETERINARY PATHOLOGY (2007)
Reevaluation of the University of Wisconsin 2-year protocol for treating canine lymphosarcoma
Claire Inderbinen Kaiser et al.
JOURNAL OF THE AMERICAN ANIMAL HOSPITAL ASSOCIATION (2007)
Distinct B-cell and T-cell lymphoproliferative disease prevalence among dog breeds indicates heritable risk
JF Modiano et al.
CANCER RESEARCH (2005)
Influence of asparaginase on a combination chemotherapy protocol for canine multicentric lymphoma
AB Jeffreys et al.
JOURNAL OF THE AMERICAN ANIMAL HOSPITAL ASSOCIATION (2005)
Prognostic significance of morphological subtypes in canine malignant lymphomas during chemotherapy
F Ponce et al.
VETERINARY JOURNAL (2004)
Chromosome aberrations in canine multicentric lymphomas detected with comparative genomic hybridisation and a panel of single locus probes
R Thomas et al.
BRITISH JOURNAL OF CANCER (2003)
Share Paper
